Staphylococcus aureus may contain one or more genes that encode a variety of immunomodulatory pyrogenic toxins (PTs), including the staphylococcal enterotoxins and toxic shock syndrome toxin (TSST). The PTs interact with several cellular targets to produce disease, such as food poisoning and toxic shock syndrome. At present, nine serologically distinct enterotoxins and one immunoreactive form of TSST have been identified and characterized. As isolates of S. aureus are further assessed, it is anticipated that this number will increase. To facilitate screening, a multiplex PCR was designed to simultaneously determine which of these 10 currently known PT genes an individual S. aureus isolate possesses. We show here, using S. aureus isolates with characterized PT phenotypes, that this novel PCR technique reliably detects each of the known PTs in a single reaction.
Staphylococcus aureus is a common pathogen that colonizes and produces disease in a variety of hosts. The ability of this bacterium to successfully persist within this range of hosts is largely due to the expression of a battery of virulence factors which promote adhesion, acquisition of nutrients, and evasion of host immunologic responses (18) . Among these is the pyrogenic exotoxin (PT) family, which is comprised of several structurally and biologically related proteins expressed by both S. aureus and Streptococcus pyogenes (22) .
PTs, which include toxic shock syndrome toxin (TSST) and the staphylococcal enterotoxins (SEs), are secreted proteins that interact with antigen-presenting cells and T lymphocytes to induce cellular proliferation (12) and high-level cytokine expression (9) . This activity does not involve the endocytic processing required for typical antigen presentation but instead occurs by concurrent association with major histocompatibility complex class II molecules of the antigen-presenting cells and the V␤ domain of the lymphocyte T-cell receptor (13) . This interaction activates a much greater percentage of the host T-cell repertoire than that induced by antigens presented in the traditional manner (15) , explaining the massive cytokine expression and subsequent immunomodulation brought about by these toxins. Proteins which have the capacity to interact with the host immunological system in this manner have been termed superantigens (SAgs), and the PTs are prototypic examples of bacterial SAgs (10) .
The SEs and TSST are the causative agents of toxic shock syndrome (6) . Additionally, unlike the other members of the PT family, the SEs have the unique ability to induce staphylococcal food poisoning, a common form of gastroenteritis (10). Presently, nine major antigenic types of SEs have been reported (SEA, SEB, SEC, SED, SEE, SEG, SEH, SEI, and SEJ), while only one serotype of TSST (comprised of TSST-1 and TSST ovine ) has been described (1, 4, 5, 8, 19, 20, 24, 25) . The SEC serotype is heterogenous and contains several antigenic and sequence molecular variants, designated SEC1, SEC2, SEC3, SEC bovine , and SEC ovine . These have been classified on the basis of minor antigenic differences and the animal host with which they are associated (17) . Because of the significance of these toxins for public health and food safety, an efficient means for screening is needed. Also, since several of these toxins have been discovered in very recent years, there is reason to believe that as research on pathogenic S. aureus isolates continues, additional SAgs will be described. Identification of novel toxins will require an efficient means to screen isolates for previously described staphylococcal PT genes. Toxigenic isolates that do not harbor genes for currently recognized toxins are likely to express novel SAgs. Therefore, we developed a multiplex PCR procedure which will rapidly and simultaneously assess whether staphylococcal isolates harbor sea, seb, sec, sed, see, seg, seh, sei, and sej, encoding the SEs, and tst, which encodes TSST.
Bacterial strains and DNA isolation. Developing and testing of the multiplex procedure was accomplished with DNA from the bacterial strains listed in Table 1 . Collectively, these isolates contain all of the previously reported PT genes. Staphylococcal genomic DNA was obtained from lysostaphin-treated cells by a previously described process (7) . The DNA was extracted with phenol and chloroform and was ethanol precipitated by standard methods (21) . The DNA was recovered by centrifugation, vacuum dried, resuspended in 200 l of pyrogen-free H 2 O, quantified spectrophotometrically at 260 and 280 nm, and diluted to a final concentration of 10 ng/l.
PCR primer design and amplification of bacterial DNA. Nucleotide sequences for each of the PT genes were obtained from GenBank by using their specific accession numbers (Table 2). The sequences were compared and evaluated by using Genetics Computer Group (Madison, Wis.) computer software to identify nucleotide sequences unique to each gene. With the exception of the seb-sec primer set, which produces a 643-bp amplification product common to both seb and sec, all primer sets were designed to anneal to unique regions and generate amplification products that would allow identification of each PT gene based on the molecular weight of its PCR product (Table 2 ). To discriminate whether the 643-bp seb-sec amplification product is indicative of either seb or sec, a separate 5Ј sec primer was designed that works in combination with the 3Ј seb-sec primer to produce a 283-bp amplification product unique to sec, including the bovine variant (see below). Additionally, to ensure that toxin-negative samples were interpreted correctly and that a sufficient quantity of PCR template DNA was present, the samples were also tested by PCR with a primer set that anneals to the S. aureus 16S rRNA gene that generates a 228-bp amplicon during the amplification process ( Table 2 ).
The multiplex PCR was performed in a 50-l volume with the Gibco BRL Taq DNA polymerase system (Life Technologies, Inc., Rockville, Md.) containing the following: 1ϫ Taq polymerase buffer, 4 mM MgCl 2 , 300 nM concentrations of each of the primers listed in Table 2 , 400 M concentrations of deoxynucleoside triphosphates, 5 U of Taq polymerase, and 50 ng of staphylococcal DNA. Bulk solutions containing the Taq buffer, MgCl 2 , deoxynucleoside triphosphates, and multiplex PCR primer mix at the appropriate concentrations were prepared for the desired number of reactions. Aliquots of the staphylococcal template DNA (50 ng in 5 l) from each test strain were individually placed into 500-l thin-walled PCR tubes. Afterwards, 40 l of the bulk solution was added to each tube containing the template DNA and covered with 50 l of mineral oil. These tubes were subsequently incubated for 10 min (95°C), during which (after the initial 3 min) 5 U of Taq polymerase (in 5 l [total volume] of 1ϫ Taq buffer) was added to each reaction. Following this "hot-start" procedure, DNA was amplified in an Amplitron II thermocycler (Barnstead Thermolyne
PCR products were resolved by electrophoresis in 1.5% agarose (0.5ϫ Tris boric acid, EDTA) gels at 100 V (constant voltage) and visualized on a transilluminator with a charged coupled device camera and the Molecular Analyst software (Bio-Rad, Hercules, Calif.). Product sizes were determined by using the 1 Kb Plus DNA molecular weight ladder (Life Technologies, Inc.).
Genetic analysis of clinical strains using the multiplex PCR procedure. Analyses using DNA obtained from the staphylo- a Primer sequences are given in the 5Ј33Ј direction. For each primer pair the sequence of the 5Ј primer is provided first (above), followed by that of the 3Ј primer (below).
b Staphylococcal PT gene identical to designation in first column unless otherwise noted in parentheses. c Location of primer sequence within open reading frame using the nucleotide numbering indicated in GenBank. d Predicted PCR product size generated by using the indicated gene-specific primer pair. For instance, the sea primer pair produces a 520-bp amplicon when the gene encoding SEA is present in the reaction mixture.
coccal isolates demonstrated that all primer pairs produced amplification products consistent with their predicted sizes. For example, amplification of DNA from FRI913, known to produce SEA, SEC, SEE and TSST-1 (3), generated bands indicative of sea (520 bp), sec (643 and 283 bp), see (170 bp), and tst (559 bp) (Fig. 1) . Similarly, amplification of DNA obtained from S. aureus MN HOCH (7), FRI472 (16), FRI326 (16), FRI572 (19) , FRI569 (24) , and FRI445 (19) produced PCR products consistent with the toxin genes that had previously been reported for these strains (Table 1 and Fig. 1 ). As expected, while amplification of DNA obtained from the nontoxigenic strain RN4220 consistently produced the 16S rRNA gene amplicon (results not shown), it failed to produce any SE-related PCR product when subjected to the multiplex PCR analysis. Since a single isolate may contain multiple toxin genes, we assessed the number of genes which could be simultaneously detected with this process under these particular reaction conditions. Using DNA pooled from several isolates (FRI913, FRI472, and FRI569), we demonstrated that it was possible to simultaneously generate PCR products representative of all 10 PT genes, as well as the 16S rRNA gene, in a single reaction (results not shown).
By design, amplification of DNA obtained from strains producing SEC were expected to result in the production of the 643-and 283-bp amplification products indicative of sec, like that observed for FRI913 (Fig. 1) . However, strains known to express SEC bovine did not generate both amplicons when tested by this procedure. Amplification of DNA obtained from the SEC bovine ϩ strain 3169 ( Fig. 1) (17) resulted in the production of the 283-bp amplicon but did not produce the 643-bp seb-sec PCR product typically observed in analyses of SEB-or SECexpressing isolates (MN HOCH and FRI913, respectively) ( Fig. 1) . This finding, which was also observed when DNA isolated from another known SEC bovine -producing S. aureus isolate was tested (results not shown), suggests that the gene encoding SEC bovine has unique attributes not shared by other sec genes (see below). The 5Ј seb-sec primer was designed to anneal to these genes at a conserved sequence within the region encoding the signal peptides of SEB and SEC. Since amplification of DNA derived from SEC bovine producers does not result in the production of the 643-bp amplicon, it is likely that the region of the gene encoding the SEC bovine signal peptide is comprised of a nucleotide sequence dissimilar to that of the other sec variants. At present, the nucleotide sequence within this portion of the SEC bovine gene is not available in GenBank and, therefore, cannot be directly compared to analogous regions of the other sec variants.
The multiplex PCR process described in this report reliably detects the genes for all staphylococcal PTs reported as of April 1999. Moreover, this technique was shown to be able to detect at least four different SE genes (producing five separate PCR products) in a single bacterial isolate. The fact that it can simultaneously detect all 10 genes in a pooled sample of DNA ensures that this procedure can both confirm the presence of PT genes previously associated with a particular strain and detect other currently known toxin genes within the isolate. For instance, in the present study S. aureus FRI472, previously described as a SED producer (1), consistently generated a 384-bp PCR product, confirming the presence of the sed gene within its genome. However, amplicons with molecular sizes of 143, 327, and 465 bp were also produced, indicating that FRI472 contains genes encoding SEJ, SEG, and SEI, respectively, as well (Fig. 1 ). This observation is consistent with the recent report by Zhang et al. (25) , who determined that the SEJ determinant is present on the same plasmid as the SED determinant. Similarly, we also showed that other isolates, such as S. aureus FRI572 and FRI445, carry toxin genes not previously associated with these isolates (Fig. 1) .
This work has produced a system that expands the capabilities of the multiplex PCR procedures previously developed by several other investigators (2, 11, 14, 23) . Most notably, the system described in this report reliably, rapidly, and simultaneously detects each of the 10 currently described staphylococcal toxin determinants, including the most recently described seg (19) , sei (19) , and sej (25) genes. Additionally, in a single reaction, the process generates amplicons that allow easy discrimination of the determinants an isolate carries, regardless of the number of PT genes carried by the isolate. These features allow this procedure to be applied in the clinical setting for epidemiological studies or to guide therapeutic strategies. This efficient method of screening isolates for PT genes could also facilitate the identification of additional genes encoding novel, yet-undescribed toxins.
FIG. 1. Agarose gel electrophoresis of the multiplex PCR amplification products from analysis of bacterial test strains. Lanes contain amplification products of DNA isolated from strains designated at top. Product identification was facilitated by direct comparison to the 1 Kb Plus (Gibco BRL) molecular weight ladder (far left lane) and a PT gene amplification product ladder prepared by pooling reaction products generated in individual reactions (far right lane).
